Knott David M Jr - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 36 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Knott David M Jr ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$207
-99.9%
18,0000.0%0.08%
-10.3%
Q3 2022$207,0000.0%18,0000.0%0.09%0.0%
Q2 2022$207,0000.0%18,0000.0%0.09%
+31.8%
Q1 2022$207,0000.0%18,0000.0%0.07%
-5.7%
Q4 2021$207,000–18,000–0.07%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders